ASTER INSIGHTS Trademark

Trademark Overview


On Tuesday, March 21, 2023, a trademark application was filed for ASTER INSIGHTS with the United States Patent and Trademark Office. The USPTO has given the ASTER INSIGHTS trademark a serial number of 97849603. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, June 18, 2024. This trademark is owned by M2Gen, Corp.. The ASTER INSIGHTS trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Providing an electronic database for the collection and storage of clinical and molecular data derived from a patient, namely, an electronic database featuring medical information in the field of human clinical and molecular data analysis for aiding medical diagnostics, discovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; Health care services, namely, providing a database in the field of cancer and other disease medical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness, namely, providing medical information data regarding tumor-specific molecular signatures, providing objective medical information data on the effectivenes...

Providing an electronic database for the collection and storage of clinical and molecular data derived from a patient, namely, an electronic database featuring medical and scientific research information in the field of human clinical and molecular data analysis for aiding medical diagnostics, discovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; medical and scientific research data analysis and bioinformatics consulting services relating thereto, namely, computer software consulting, providing online non-downloadable computer software platforms for analyzing medical and scientific research data, and scientific research data analytics consulting in connection with an electronic database for the collection and storage of medical and scientific research information in the fields of clinical and molecular data accumulated for aiding medical diagnostic, discovery and development and prognostics an...
aster insights

General Information


Serial Number97849603
Word MarkASTER INSIGHTS
Filing DateTuesday, March 21, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, June 18, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2024

Trademark Statements


Goods and ServicesProviding an electronic database for the collection and storage of clinical and molecular data derived from a patient, namely, an electronic database featuring medical information in the field of human clinical and molecular data analysis for aiding medical diagnostics, discovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; Health care services, namely, providing a database in the field of cancer and other disease medical information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Providing a database in the field of human clinical and molecular data accumulation and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness, namely, providing medical information data regarding tumor-specific molecular signatures, providing objective medical information data on the effectiveness of a drug and/or diagnostic test, and providing evidence-based treatment protocols by effectively comparing standard treatment therapies with clinical outcomes; collection and analysis of data services in the field of human clinical and molecular data for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases, namely, medical services in the nature of matching particular patients to a particular drug, treatment, therapy or clinical trial by the specific molecular signature of the patient; providing an Internet-accessible website portal featuring medical records for use by physicians, patients and researchers for the storage and accessibility of electronic medical information data in the field of human clinical and molecular data and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services.
Goods and ServicesProviding an electronic database for the collection and storage of clinical and molecular data derived from a patient, namely, an electronic database featuring medical and scientific research information in the field of human clinical and molecular data analysis for aiding medical diagnostics, discovery and development and prognostics and the evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; medical and scientific research data analysis and bioinformatics consulting services relating thereto, namely, computer software consulting, providing online non-downloadable computer software platforms for analyzing medical and scientific research data, and scientific research data analytics consulting in connection with an electronic database for the collection and storage of medical and scientific research information in the fields of clinical and molecular data accumulated for aiding medical diagnostic, discovery and development and prognostics and evaluation and testing of drug and treatment effectiveness relating to cancer and other diseases; providing an Internet-accessible website portal featuring medical records for use by physicians, patients and researchers for the storage and accessibility of electronic medical research data in the field of human clinical and molecular data and analysis for aiding medical diagnostics, prognostics and the evaluation and testing of drug and treatment effectiveness; providing consulting services relating thereto for the aforementioned services

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 12, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameM2Gen, Corp.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressHudson, FL 34677

Party NameM2Gen, Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHudson, FL 34677

Trademark Events


Event DateEvent Description
Friday, March 24, 2023NEW APPLICATION ENTERED
Wednesday, April 12, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 15, 2023ASSIGNED TO EXAMINER
Monday, December 18, 2023NON-FINAL ACTION WRITTEN
Monday, December 18, 2023NON-FINAL ACTION E-MAILED
Monday, December 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, February 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 28, 2024NON-FINAL ACTION WRITTEN
Wednesday, February 28, 2024NON-FINAL ACTION E-MAILED
Wednesday, February 28, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, March 21, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, March 21, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, March 21, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 21, 2024EXAMINER'S AMENDMENT ENTERED
Thursday, March 21, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, April 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, April 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 11, 2024TEAS STATEMENT OF USE RECEIVED